Breaking
Friday, June 19, 2026

FDA News

🇺🇸 FDA Page 3

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.

Showing 25–36 of 391 articles

High impact NewsJun 8, 2026

Cardiff Oncology pipeline update: onvansertib trials, FDA meeting, and catalysts

FDA · oncology · 5 min

Dr. Sarah Mitchell
Critical impact NewsJun 8, 2026

Syndax pipeline update: Revuforj and Niktimvo catalysts to watch

FDA · 8 min

Dr. Sarah Mitchell
Critical impact NewsJun 8, 2026

FDA Approves Lumasiran for PH1: What BD and Investors Should Know

FDA · Acute Hepatic Porphyria · 8 min

Dr. Sarah Mitchell
High impact NewsJun 7, 2026

Novo Nordisk supply of Wegovy stabilizes as new capacity comes online

FDA · weight loss · 4 min

Dr. Sarah Mitchell
High impact AnalysisJun 7, 2026

Vabysmo gains EU approval for retinal vein occlusion: what changes next

FDA · retinal vein occlusion · 6 min

Dr. Sarah Mitchell
High impact NewsJun 7, 2026

GSK’s Blenrep returns to the US market after FDA approves resubmission

FDA · blood cancer · 5 min

Dr. Sarah Mitchell
Critical impact NewsJun 7, 2026

Moderna mRNA-1083 Phase 3 data show stronger flu and COVID immune response

FDA · COVID-19 · 6 min

Dr. Sarah Mitchell
High impact AnalysisJun 7, 2026

FDA approves Vertex’s Journavx as first non-opioid pain drug for acute pain

FDA · moderate-to-severe acute pain · 7 min

Dr. Sarah Mitchell
High impact NewsJun 7, 2026

FDA approves Vyloy for HER2-negative gastric and GEJ cancer

FDA · HER2-negative gastric cancer · 5 min

Dr. Sarah Mitchell
High impact NewsJun 7, 2026

Novo Nordisk supply of Wegovy stabilizes as FDA shortage ends

FDA · weight-loss · 5 min

Dr. Sarah Mitchell
Critical impact AnalysisJun 7, 2026

Lenacapavir posts 100% HIV prevention in PURPOSE 1

FDA · HIV · 8 min

Dr. Sarah Mitchell
High impact AnalysisJun 7, 2026

Cobenfy meets endpoint in Bristol Myers Squibb’s Alzheimer’s psychosis trial

FDA · Alzheimer's disease · 6 min

Dr. Sarah Mitchell